Skip to main content
Clinical Trials/NCT06542601
NCT06542601
Recruiting
Not Applicable

Effect of Combined Motor and Cognitive Training on Older Adults With Motoric Cognitive Risk Syndrome in Community: a Randomized Controlled Study

Xuanwu Hospital, Beijing1 site in 1 country204 target enrollmentJuly 4, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Disability Physical
Sponsor
Xuanwu Hospital, Beijing
Enrollment
204
Locations
1
Primary Endpoint
Cognitive function changes in the intervention group and the control group
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

To investigate the effects of a combined motor-cognitive intervention on the improvement of motor as well as cognitive function in community residents.

Detailed Description

Cognitive training uses systematically designed tasks that are difficulty-adaptive for cognitive domains such as attention, memory, and logical reasoning to improve individual cognitive functioning. Internet-based Adaptive Multi-Cognitive Domain Cognitive Training is conducted 3 times per week for 30 minutes each time, and includes tasks such as delayed memory, paired memory, and inverse numerical breadth. The exercise intervention was based on the M-Mobile multicomponent exercise program, in which older adults were instructed to complete exercise training at home at least three days per week. In all intervention groups, balance, sitting test and walking speed were assessed according to the Simple Physical Performance Battery (SPPB), and according to their scores, they were given exercise training, including flexibility, balance, aerobic training and resistance training.

Registry
clinicaltrials.gov
Start Date
July 4, 2024
End Date
June 30, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 60-80 years; ≥ 9 years of education; Cognitive impairment: MMSE score 22-26; Slow gait:total walking time \>4 seconds and ≤8 seconds in a 4-meter walk test; Agreed to participate in the study and signed an informed consent form.

Exclusion Criteria

  • Dementia/suspected dementia; Suffering from diseases that affect cognitive function, such as cerebrovascular disease, Parkinson's syndrome, etc.; Taking medications related to cognitive improvement and psychiatric disorders, etc.; Recent heart attack, severe cerebrovascular disease, psychiatric disorders, etc.; other inability to persist in completing exercise cognitive interventions, such as suffering from severe musculoskeletal disorders; Participating in another clinical trial at the same time; Participation in an exercise and/or cognitive intervention in the past 6 months; Inability to complete content in studies such as neuropsychological scale assessments.

Outcomes

Primary Outcomes

Cognitive function changes in the intervention group and the control group

Time Frame: 12 weeks

Changes in Montreal Cognitive Assessment Scale (MoCA) scores before and after intervention between the two groups

Motor function changes in the intervention group and the control group

Time Frame: 12 weeks

Changes in Montreal Short Physical performance Battery (SPPB) scores before and after intervention between the two groups

Study Sites (1)

Loading locations...

Similar Trials